Fraxiparine 5700IU Injection
By Fraxiparine
Rx
0ml Injection in a Vial

Composition
Nadroparin(5700IU)

Manufacturer - Glaxo SmithKline Pharmaceuticals Ltd
Dr. Annie Besant Road, Mumbai - 400 030

Expires on or after
October, 2025

liver
There is limited information available on the use of Fraxiparine 5700IU Injection in patients with liver disease. It is important to consult your doctor before using this injection if you have any liver issues. Your doctor will be able to provide guidance on the appropriate use of Fraxiparine 5700IU Injection based on your liver condition. Take caution and seek medical advice to ensure the safe and effective use of this injection in relation to liver health.

kidney
Fraxiparine 5700IU Injection requires caution in severe kidney disease. Dosage adjustment may be necessary. Always seek advice from your doctor.

alcohol
It is not known whether it is safe to consume alcohol with Fraxiparine 5700IU Injection. Please consult your doctor.

driving
When using Fraxiparine 5700IU Injection, it is uncertain if it affects driving ability. Avoid driving if you have symptoms that disturb focus and reaction time.

pregnancy
Fraxiparine 5700IU Injection may not be safe to use during pregnancy. Limited human studies suggest potential harm to the developing baby. Your doctor will assess benefits versus risks before prescribing. Please consult your doctor.

breastfeeding
Fraxiparine 5700IU Injection may be unsafe while breastfeeding, as it may pass into breastmilk and potentially harm the baby.
Habit Forming | No |
Chemical Class | Low molecular weight heparin (LMWH) |
Therapeutic Class | BLOOD RELATED |
Action Class | Low molecular weight Heparin (LMWH) |
₹475
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024